This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Cromoglycid acid containing nasal spray. The patient applies Ectoin Allergy Nasal Spray or Cromoglycid acid containing nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and by the patient in a dairy at defined time intervalls.
Study Type
OBSERVATIONAL
Enrollment
50
Ectoin (R) Allergy Nasal Spray
HNO Praxis Elmshorn
Elmshorn, Germany
Change in combined nasal symptom Score
The change in the sum of the three different parameters nasal congestion, rhinorrhea and nasal errhine were investigated as combined score.
Time frame: Time Frame: day 1, day 7, day 14
Patient's and physician's judgment of efficacy
Patient and physician were asked to grade the efficacy of the treatment on a scale from 0 to 8.
Time frame: Day 7 and 14
Eye itching score,
Time frame: Day 1, 7, 14
Epiphora score
Time frame: Day1, Day 7 and Day 14
Conjunctivitis score,
Time frame: Day 1, Day 7 Day 10
Palatal itching score
Time frame: Day 1, Day 7, Day 14
Nasal muscle hyperplasia score
Time frame: Day 1, Day 7 and Day 14
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.